|
JP3309982B2
(ja)
|
1992-03-13 |
2002-07-29 |
メルク シヤープ エンド ドーム リミテツド |
イミダゾール，トリアゾールおよびテトラゾール誘導体
|
|
GB9207396D0
(en)
|
1992-04-03 |
1992-05-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US5952294A
(en)
|
1996-07-31 |
1999-09-14 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptidyl prodrugs and methods of making and using the same
|
|
JP4109123B2
(ja)
|
2001-05-09 |
2008-07-02 |
セルメド オンコロジー （ユーエスエイ）， インコーポレイテッド |
ペプチドデホルミラーゼ活性化プロドラッグ
|
|
US6642390B2
(en)
|
2001-07-11 |
2003-11-04 |
Lexicon Pharmaceuticals, Inc. |
One step synthesis of 1,2,3-triazole carboxylic acids
|
|
US7105548B2
(en)
|
2001-12-18 |
2006-09-12 |
Merck & Co., Inc. |
Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
|
|
JP2005529889A
(ja)
|
2002-04-26 |
2005-10-06 |
ファイザー・プロダクツ・インク |
ピリミジン−２，４，６−トリオンメタロ−プロテイナーゼ阻害剤
|
|
US7354938B2
(en)
*
|
2004-03-23 |
2008-04-08 |
Amgen Inc. |
Pyrazole compounds and uses related thereto
|
|
TWI309240B
(en)
|
2004-09-17 |
2009-05-01 |
Hoffmann La Roche |
Anti-ox40l antibodies
|
|
KR101340859B1
(ko)
|
2005-02-04 |
2013-12-13 |
세노믹스, 인코포레이티드 |
연결형 헤테로 아릴 잔기를 포함한 화합물, 및 식용조성물을 위한 신규의 우마미 향미 개선제, 맛 촉진물질 및맛 향상제로서의 그의 용도
|
|
WO2006091898A2
(en)
*
|
2005-02-25 |
2006-08-31 |
Adenosine Therapeutics, Llc |
Pyrazolyl substituted xanthines
|
|
WO2006105021A2
(en)
|
2005-03-25 |
2006-10-05 |
Tolerrx, Inc. |
Gitr binding molecules and uses therefor
|
|
EA019344B1
(ru)
|
2005-07-01 |
2014-03-31 |
МЕДАРЕКС, Эл.Эл.Си. |
Человеческие моноклональные антитела против лиганда-1 запрограммированной гибели клеток (pd-l1) и их применения
|
|
CA2849661A1
(en)
|
2006-03-17 |
2007-09-27 |
Gilead Sciences, Inc. |
Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
|
|
WO2008004942A1
(en)
|
2006-07-04 |
2008-01-10 |
Astrazeneca Ab |
New pyridine analogues
|
|
US7994321B2
(en)
|
2006-08-08 |
2011-08-09 |
Hoffmann-La Roche Inc. |
Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
CA2693677C
(en)
|
2007-07-12 |
2018-02-13 |
Tolerx, Inc. |
Combination therapies employing gitr binding molecules
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
EP2249853A4
(en)
|
2008-01-30 |
2012-12-26 |
Univ Indiana Res & Tech Corp |
ESTER BASED PEPTIDE PRODRUGS
|
|
PE20091953A1
(es)
|
2008-05-08 |
2010-01-09 |
Du Pont |
Azoles sustituidos como fungicidas
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
CA2733554A1
(en)
|
2008-08-18 |
2010-02-25 |
Yale University |
Mif modulators
|
|
HUE065752T2
(hu)
|
2008-12-09 |
2024-06-28 |
Hoffmann La Roche |
Anti-PD-L1 antitestek és felhasználásuk T-sejt funkció elõsegítésére
|
|
CN102388037B
(zh)
*
|
2009-02-10 |
2014-12-03 |
詹森药业有限公司 |
作为脯氨酰羟化酶抑制剂的喹唑啉酮
|
|
WO2010108187A2
(en)
|
2009-03-20 |
2010-09-23 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
|
WO2010144780A1
(en)
|
2009-06-12 |
2010-12-16 |
University Of Kansas |
Compositions and methods for establishing and maintaining stem cells in an undifferentiated state
|
|
EP2451286B8
(en)
|
2009-07-08 |
2018-04-04 |
ISP Investments LLC |
4- and 5 substituted 1,2,3- triazole moieties with at least one remote polymerizable moiety and polymers thereof
|
|
RU2595409C2
(ru)
|
2009-09-03 |
2016-08-27 |
Мерк Шарп И Доум Корп., |
Анти-gitr-антитела
|
|
WO2011050284A1
(en)
*
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Pyrazolylpyridine antiviral agents
|
|
AU2010329934B2
(en)
|
2009-12-10 |
2015-05-14 |
F. Hoffmann-La Roche Ag |
Antibodies binding preferentially human CSF1R extracellular domain 4 and their use
|
|
US20130030359A1
(en)
|
2010-01-22 |
2013-01-31 |
Ascendis Pharma A/S |
Dipeptide-based prodrug linkers for aromatic amine-containing drugs
|
|
WO2011107530A2
(en)
|
2010-03-03 |
2011-09-09 |
Probiodrug Ag |
Novel inhibitors
|
|
DK2542256T3
(da)
|
2010-03-04 |
2019-08-26 |
Macrogenics Inc |
Antistoffer reagerende med b7-h3, immunologisk aktive fragmenter deraf og anvendelser deraf
|
|
CA2789071C
(en)
|
2010-03-05 |
2018-03-27 |
F. Hoffmann-La Roche Ag |
Antibodies against human csf-1r and uses thereof
|
|
MX2012010014A
(es)
|
2010-03-05 |
2012-09-21 |
Hoffmann La Roche |
Anticuerpos contra csf-1r humano y sus usos.
|
|
EP2560966B1
(en)
|
2010-03-30 |
2021-01-06 |
Verseon International Corporation |
Multisubstituted aromatic compounds as inhibitors of thrombin
|
|
MX355418B
(es)
|
2010-05-04 |
2018-04-18 |
Five Prime Therapeutics Inc |
Anticuerpos que se unen a factor estimulante de colonias 1 (csf1r).
|
|
CN103221428B
(zh)
|
2010-09-09 |
2016-02-10 |
辉瑞公司 |
4-1bb结合分子
|
|
US8748435B2
(en)
*
|
2011-04-01 |
2014-06-10 |
Novartis Ag |
Pyrazolo pyrimidine derivatives
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
KR101981873B1
(ko)
|
2011-11-28 |
2019-05-23 |
메르크 파텐트 게엠베하 |
항-ｐｄ-ｌ1 항체 및 그의 용도
|
|
WO2013085890A1
(en)
|
2011-12-06 |
2013-06-13 |
Glaxo Group Limited |
Therapeutic methods
|
|
US10023643B2
(en)
|
2011-12-15 |
2018-07-17 |
Hoffmann-La Roche Inc. |
Antibodies against human CSF-1R and uses thereof
|
|
EP2812355A4
(en)
|
2012-02-06 |
2016-03-02 |
Hoffmann La Roche |
COMPOSITIONS AND METHODS OF USE OF CSF1R INHIBITORS
|
|
ES2816060T3
(es)
*
|
2012-02-29 |
2021-03-31 |
Chemocentryx Inc |
Aza-aril 1H-pirazol-1-il-bencenosulfonamidas como antagonistas de CCR(9)
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
DE102012102162A1
(de)
|
2012-03-14 |
2013-09-19 |
Westfälische Wilhelms-Universität Münster Körperschaft des öffentlichen Rechts |
Ionenleitende polymere Verbindung für elektrochemische Zellen
|
|
JP2015517490A
(ja)
|
2012-05-11 |
2015-06-22 |
ファイブ プライム セラピューティックス インコーポレイテッド |
コロニー刺激因子１受容体（ｃｓｆ１ｒ）を結合させる抗体を用いて状態を治療する方法
|
|
UY34887A
(es)
|
2012-07-02 |
2013-12-31 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
|
|
SG10201906328RA
(en)
|
2012-08-31 |
2019-08-27 |
Five Prime Therapeutics Inc |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
US9365527B2
(en)
|
2013-03-14 |
2016-06-14 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
|
WO2015031824A1
(en)
|
2013-08-30 |
2015-03-05 |
Icahn School Of Medicine At Mount Sinai |
Cyclic vinylogous amides as bromodomain inhibitors
|
|
EP2903044A1
(de)
|
2014-02-04 |
2015-08-05 |
cynora GmbH |
Organische Moleküle zur Verwendung in optoelektronischen Bauelementen
|
|
US10052332B2
(en)
|
2014-04-29 |
2018-08-21 |
Emory University |
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
|
|
US20160251341A1
(en)
|
2015-02-27 |
2016-09-01 |
Verseon Corporation |
Substituted triazole compounds as serine protease inhibitors
|
|
CN108472284A
(zh)
|
2015-09-11 |
2018-08-31 |
维纳拓尔斯制药公司 |
β-内酰胺酶抑制剂
|
|
TWI812494B
(zh)
|
2017-01-20 |
2023-08-11 |
美商阿克思生物科學有限公司 |
用於治療癌症相關病症之唑嘧啶
|
|
CN110612100B
(zh)
|
2017-05-05 |
2023-04-14 |
艾库斯生物科学有限公司 |
治疗与癌症有关疾病的喹唑啉-吡啶衍生物
|